S. Agarwal1, V. Gunaseelan1, J. V. Vu1, J. F. Waljee1, C. M. Brummett2, M. J. Englesbe1, J. S. Lee1 1University Of Michigan,Department Of Surgery,Ann Arbor, MI, USA 2University Of Michigan,Department Of Anesthesiology,Ann Arbor, MI, USA
Introduction: Opioid prescription and consumption have not been well characterized in patients undergoing abdominal surgery. Moreover, the impact of the indication for surgery on opioid prescription and consumption has not been well-described. The objective of this study was to compare differences in opioid prescribing and consumption for cancer and non-cancer patients undergoing abdominal surgery.
Methods: colectomy and hysterectomy from January – December 2017. The quantity of opioid prescribed for the initial postoperative prescription and patient-reported opioid consumption were converted to the equivalent number of tablets of 5 mg oxycodone for ease of interpretation. The primary outcomes of this study were the mean quantity of opioid prescribed and consumed. Patients were stratified by type of procedure and whether or not they underwent surgery for a cancer diagnosis. The Wilcoxon signed rank sum test was used to compare the mean quantity of opioid prescribed and consumed in each group.
Results: In this study, 869 patients underwent abdominal surgery. Of these, 241 underwent elective colectomy and 628 underwent elective hysterectomy. Figure 1 compares the mean quantity of opioid prescribed and consumed with patients stratified by procedure type and cancer diagnosis. Patients who underwent colectomy were prescribed significantly more opioid than they consumed for both cancer patients (26 vs. 7 tablets of 5 mg oxycodone, P < 0.001) and non-cancer patients (29 vs. 14 tablets of 5 mg oxycodone, P < 0.001). Similarly, patients who underwent elective hysterectomy were prescribed significantly more opioid than they consumed for both cancer patients (28 vs. 11 tablets of 5 mg oxycodone, P < 0.001) and non-cancer patients (25 vs. 11 tablets of 5 mg oxycodone, P < 0.001).
Conclusion: Patients undergoing abdominal surgery were prescribed significantly more opioid than they consumed for both cancer and non-cancer operations. Future guidelines for prescribing opioids should consider indications for surgery in addition to patient demographic and procedural characteristics.